What the studies show
Khavinson's 2011 study reports lower free-radical levels and less necrotic death in cultured cells — the origin of the neuroprotection claim.
Animal studies, cell studies, or anecdotes only. This is where almost every viral peptide sits. Promising and proven are different words for a reason.
- 1Khavinson V, et al. Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes.Rejuvenation Res, 2011Cell culture.
In context
Pinealon is the tripeptide Glu-Asp-Arg, a synthetic 'bioregulator' from the St Petersburg group behind epitalon, sold for brain ageing and stress. Its indexed evidence is cell culture — it reduced free radicals and cell death in vitro — and rat experiments in hypoxia. The human reports are Russian-language, without controls and without indexed abstracts. No randomised trial exists. It is not approved anywhere this site covers.
Pinealon is not approved. Legal status differs by country — see the regulation section or the jurisdiction pages.
Questions
Is Pinealon proven to help with cell viability under oxidative stress?
What studies are behind the grade?
Is Pinealon approved for this?
Other outcomes for Pinealon
- DCognition or brain ageing (human)0 controlled; Russian reports without abstracts
- DHypoxia tolerance (rats)Animal only
Written and maintained by LYO Research — how pages are written and checked. Reviewed 23 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →